Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

Archive ouverte

Ilié, Marius | Mazières, Julien | Chamorey, Emmanuel | Heeke, Simon | Benzaquen, Jonathan | Thamphya, Brice | Boutros, Jacques | Tiotiu, Angélica | Fayada, Julien | Cadranel, Jacques | Poudenx, Michel | Moro-Sibilot, Denis | Barlesi, Fabrice | Thariat, Juliette | Clément-Duchêne, Christelle | Tomasini, Pascale | Hofman, Véronique | Marquette, Charles-Hugo | Hofman, Paul | Israel-Biet, Dominique | Pison, Christophe | Lantuejoul, Sylvie | Stephanov, Olivier | Juliette, Meyzenc | Mendozat, Christophe | Zaidi, Manel | Coulouvrat, Sandra | Col, Edwige | Chanez, Pascal | Greillier, Laurent | Mascaux, Céline | Jourdan, Sandrine | Roger, Aurélie | Biemar, Julie | Randriamampionona, Rondro | Chabot, François | Vignaud, Jean-Michel | Lacomme, Stéphanie | Lomazzi, Sandra | Laurent, Carine | Bulsei, Xavier | Bischoff, Laura | Rakotonirina, Raymond | Layouni, Mehdi | Deslee, Gaëtan | Mal, Hervé | Kessler, Romain | Vergnon, Jean-Michel | Pelissier, Isabelle | Cuvelier, Antoine | Bourdin, Arnaud | Jounieaux, Vincent | Roche, Nicolas | Jouneau, Stéphane | Bonniaud, Philippe | Scherpereel, Arnaud | Mornex, Jean François | Steenhouwer, François | Leroy, Sylvie | Marquette, Charles Hugo | Mazzette, Andrea | Padovani, Bernard | Long-Mira, Elodie | Lassalle, Sandra | Pradelli, Johanna | Martinez, Estelle | Habault, Marine | Bonnard, Mélanie | Moutarde, Julie | Yatimi, Rachida | Labsi, Hakima | Gazoppi, Loïc | Lpce, Tumorothèque | Griffonnet, Jennifer | Fontaine, Maureen | Guillemart, Ariane | Butori, Catherine | Selva, Eric | Otto, Josiane | Hebert, Christophe | Botchiellini, Delphine | Boudouf, Soukaina | Menier, Margaux | Occeli, Estelle | Bellentani, Sophie | Pion, Carine | Fournier, Elodie | Gervais, Radj | Hamond, Karim | Marchand-Adam, Sylvain | Plantier, Laurent | Fajolle, Gaelle | Rayez, Mélanie | Fallet, Vincent | Wislez, Marie | Antoine, Martine | Cote, Jean-François | Chaabane, Nouha | Ruppert, Anne Marie | Bertrand, Eliane | Rodenas, Anita | Pontdeme, Gwenaëlle | Mathiot, Nathalie | Ribert, Tamazouzt | Guibert, Nicolas | Rouviere, Damien | Bousquet, Emilie | Bigay-Game, Laurence | Hermant, Christophe | Plat, Gavin | Rouquette, Isabelle | Evrard, Solène | Gouin, Sandrine | Clermont, Estelle Taranchon | Dormoy, Inge | Coulomb, Christelle | Pradine, Anne | Lambert, Véronique | Laborde, Lilian | Castelnau, Olivier

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience

Consulter en ligne

Suggestions

Du même auteur

Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC

Archive ouverte | Ilié, Marius | CCSD

International audience. Introduction: Patients with advanced-stage NSCLC whose tumors harbor an ALK gene rearrangement benefit from treatment with multiple ALK inhibitors (ALKi). Approximately 30% of tumor biopsy sa...

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

Archive ouverte | Marquette, Charles-Hugo | CCSD

International audience. Background Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Bloodsignatures might act as a standalone screening tool, refine the selection of...

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay

Archive ouverte | Heeke, Simon | CCSD

International audience. Background: Detection of genomic rearrangements, like anaplastic lymphoma kinase (ALK) fusions, is a pivotal requirement in non-small cell lung cancer (NSCLC) for the initiation of a targeted...

Chargement des enrichissements...